Views | |
---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 237 |
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 1 | 3 | 7 | 5 | 11 | 4 | 2 |
Views | |
---|---|
3_Chapter3_Materials_Methods.pdf | 179 |
6_Chapter6_References.pdf | 176 |
1_Chapter1_Introduction_aims_objectives.pdf | 162 |
7_Chapter7_Appendices_Aknowledgements.pdf | 140 |
0_Title_Index.pdf | 117 |
2_Chapter2_Literature_review.pdf | 83 |
4_Chapter4_Results_Discussions.pdf | 81 |
5_Chapter5_Summary_Zusammenfassung.pdf | 59 |